Morgan Stanley Shares Take a Surprise Drop

Morgan Stanley shares fell 1.2% in premarket trading after Oppenheimer downgraded the stock to "underperform," raising investor concerns about the bank's valuation, despite most analysts maintaining a positive outlook.

The stock also came under additional pressure from news that OpenAI's initial public offering (IPO) has been postponed to 2027. This could impact Morgan Stanley's revenue as one of the lead managers of the IPO, in addition to its role in the anticipated listing of Anthropic.

In contrast, BMO Capital raised its price target for Morgan Stanley to $240 while maintaining its "outperform" recommendation, citing confidence in the bank's strong fundamentals.

Despite the strong performance of the US markets, Morgan Stanley's decline bucked the market trend, reflecting pressures specific to the company related to valuation concerns and lowered expectations for AI deal fees. This prompted investors to exercise caution before the start of the trading session.